Affinity Bio Partners
Affinity Bio Partners (ABP) is a clinical research organization which works in the medical cannabis and CBD industry to provide the transformational foundation for our clients that leverages our visionary, industry leading, professional staff. ABP prides itself in being a pioneer in the medical cannabis industry. ABP appreciates working with clients that have been in clinical research for decades, as well as newly developed biotechs/nutraceutical companies including dispensaries and medical cannabis physicians. With our entrepreneurial foundation, our partnered technology platforms, we always are forward thinking, risk anticipation, and always leveraging our ability to effectively navigate in the medical cannabis landscape. Recently, ABP and their tech partner, HCXP co-developed the first ever AI Medical Cannabis/CBD Bot called the CannaBot.
We are excited to introduce one of our newest community members, Affinity Bio Partners. Christina DiArcangelo Puller and her team have been closely involved in the PA Cannabis Community over the course of the year. They spoke at Allentown City Council meetings in support of the decriminalization movements. Christina represented ABP on panel discussions at the LIT Documentary preview and Collab for a Cause. The ABP team has also helped Kenny Brownlee through his battle with Burkitt Lymphoma, providing advice, resources and physician recommendations along the way.
To learn more about Affinity Bio Partners and CannaBot, click the ABP logo to view their site.